Proteus Digital Health, Inc., a Redwood City, Calif.-based provider of a digital health feedback system, completed a second closing in its (now) $62.5m in Series F financing.
New corporate investor Oracle, joined Otsuka, Novartis, Sino Portfolio and others.
Led by Andrew Thompson, CEO, Proteus Digital Health has developed a digital health feedback system, which provides a view into an individual’s personal health choices and physiologic response, allowing patients to better manage their health and collaborate with caregivers and clinicians.
The company has received a CE mark in Europe and FDA market clearance in the U.S. for its wearable and ingestible sensor devices.
Proteus is also backed by Carlyle, Essex Woodlands, Kaiser Permanente, Medtronic, Oracle, ON Semiconductor.